Navigation Links
MEDISON Launches New Dedicated OB/GYN 3D/4D Ultrasound System, ACCUVIX V20 'Prestige'
Date:9/21/2009

SEOUL, Korea, Sept. 21 /PRNewswire/ -- MEDISON (CEO: Wongihl Sohn, www.medison.com), has announced the launch of a new dedicated high performance OB/GYN ultrasound system, featuring the industry's first multi-rendering 3D/4D technology, 3D MXI(TM) (3D Multi-eXtended Imaging(TM)) - ACCUVIX V20 'Prestige.'

"As an ultrasound manufacturer that introduced the first commercial 3D/4D ultrasound device to the world, MEDISON has been actively moving forward to innovate ultrasound imaging technology," said the director of R&D center of MEDISON headquarters. "With MEDISON's accumulated and advanced technology in ultrasound imaging industry and our consistent effort to develop better ultrasound system for caring life, I believe that the 'Prestige' takes you beyond your imagination by helping you identify and diagnose more efficiently and accurately."

The 'Prestige' is the ultrasound imaging system, offering a 19-inch high-resolution flat screen monitor and 3D MXI(TM) (3D Multi-eXtended Imaging(TM), including Multi Volume Slice(TM), Mirror View(TM), Multi-OVIX(TM), 3D Orientation Help(TM)), giving users higher quality images than ever with greater ease and improved diagnostic confidence.

Along with the cutting edge 3D MXI(TM) (3D Multi-eXtended Imaging(TM)), the 'Prestige' also comes with extended diagnostic tools including DMR+(TM) (DynamicMR+(TM)), Auto IMT(TM) and Panoramic imaging technology. With sophisticated image processing technology and automated diagnostic tools, MEDISON customers can get a rich and full experience on outstanding imaging performance and enhanced functionality for OB/GYN and general imaging as well. Especially DMR+(TM) (DynamicMR+(TM)) is fully optimized for evaluating detailed obstetrical, pelvic and abdominal anatomy.

Besides, the 'Prestige' is specially designed for optimum user comfort and workflow efficiency, provides 360 degree articulated monitor arm, ergonomic key grouping and 19-inch flat LCD with haze eliminating filter, allowing users to diagnose in ideal environment at daily practice.

The 'Prestige' will be available for global users, starting with the showcase at 19th ISUOG 2009, a world-renowned OB/GYN congress, which is being held on September 13th to 17th in Hamburg, Germany.

If you need photos, use these photos following link http://image2.aving.net/2009/09/14/20090914095720560.jpg

http://image2.aving.net/2009/09/14/20090914095734750.jpg

http://image2.aving.net/2009/09/14/20090914095743240.jpg

About MEDISON Co., Ltd

MEDISON has been a leading name in diagnostic ultrasound since its foundation in 1985. As one of companies dedicated solely to ultrasound imaging, we have remained at the forefront of research and development in 3D/4D technology for more than 20 years. Since revolutionizing the industry with the introduction of the first commercial 3D/4D ultrasound device, we have continued to innovate technologies that have made 3D/4D ultrasound an indispensable diagnostic tool for clinicians the world over. Today we continue to pioneer revolutionary ultrasound technologies and develop the ultimate in 3D/4D ultrasound imaging systems. For more information about MEDSION, visit website at www.medison.com.


'/>"/>
SOURCE MEDISON Co., Ltd
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Webmedx Launches New Data-Mining Solution for Medical Transcription and Speech-Generated Documents
2. World Health Organization Launches New Attack on Lung Cancer
3. Thomson Reuters Launches Thomson Pharma Partnering Forecast
4. https://happier.com/form.htmhappier.com Launches a Personal Trainer for Your Happiness
5. American Lung Association Launches Retro Marketing Initiative to Support 2009 Christmas Seals(R) Campaign
6. LYSOL(R) Launches Healthier Habits Rewards Program at Schools Nationwide to Help Protect Families from Germs, Such as H1N1
7. Cohen Launches Second Statewide Tour
8. Childrens Hospital of Wisconsin Launches H1N1 Prevention Campaign Geared Toward Children
9. ForteBio Launches Dip and Read(TM) Immunogenicity Assay Kit for Rapid Detection of Anti-Drug Antibodies
10. Worlds First Emergency Medical Information Franchise Launches GPS Tracking Device
11. Affinion Security Center Launches Benefits to Help Detect and Resolve Medical Identity Theft
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2017)... ... July 21, 2017 , ... MedMatchPlus+ has ... chances of acceptance to a residency in a United States hospital. Being accepted ... the U.S. , According to data released by the ECFMG®, every year, 50 ...
(Date:7/21/2017)... ... July 21, 2017 , ... Sharon ... the signature product of her research center at Bio-Logic Aqua Research® Water Life ... and the greatest number of sufferers of blindness. “We think that Nature’s Tears® ...
(Date:7/21/2017)... ... July 21, 2017 , ... In the ... from the Multicenter Orthopaedics Outcome Network (MOON) demonstrated that patients could perform sports-related ... though activity levels decline over time. The study, presented today at the ...
(Date:7/21/2017)... ONTARIO, CANADA (PRWEB) , ... July 21, 2017 ... ... give insight into why concussion rates are on the rise, say researchers presenting ... Meeting today in Toronto, Ontario, Canada. , “The combination of evaluating the patterns ...
(Date:7/20/2017)... ... 2017 , ... ChenMed , a leading provider of value-based care for ... as Richmond Chief Medical Officer. Dr. McCarter, formerly Associate Professor of Family ... of Ambulatory Services for the UVA Health System, brings 30 years of highly relevant ...
Breaking Medicine News(10 mins):
(Date:7/21/2017)... RESEARCH TRIANGLE PARK, N.C. , July ... UTHR ) announced today that it will report ... opens on Thursday, July 27, 2017. ... on Thursday, July 27, 2017, at 9:00 a.m. Eastern ... international callers dialing 1-970-315-0533.  A rebroadcast of the teleconference ...
(Date:7/20/2017)... -- Prime Therapeutics LLC (Prime) released this statement from its Chief ... for Clinical and Economic Review,s (ICER) public meeting ... of abuse-deterrent formulations (ADF) of opioids. Prime was the sole ... "The ICER data ... use of abuse-deterrent formulations (ADF) in opioids in terms of ...
(Date:7/15/2017)... Enterin Inc., a Philadelphia -based ... today announced the completion of a $12.7 million Series A ... as well as the participation of existing investors. ... the support of New Ventures III and our current investors, ... the potential of our platform technology to transform the course ...
Breaking Medicine Technology: